Clinical TrialsImmutep Links Eftilagimod Alfa Immune Activation to Survival Benefit Across... Immutep Links Eftilagimod Alfa Immune Activation to Survival Benefit Across... Read Post »
Clinical TrialsOno Reports Encouraging Phase 2 Results for ONO-2808 in MSA Ono Reports Encouraging Phase 2 Results for ONO-2808 in MSA Read Post »
Clinical TrialsIpsen Presents New Data Reinforcing IQIRVO® in PBC at EASL 2026 Ipsen Presents New Data Reinforcing IQIRVO® in PBC at EASL 2026 Read Post »
Clinical TrialsGSK’s Bepirovirsen Achieves Functional Cure in Phase 3 CHB Trials GSK’s Bepirovirsen Achieves Functional Cure in Phase 3 CHB Trials Read Post »
New Drug ApprovalIronwood and AbbVie Secure FDA Expansion for LINZESS in Young Children for ... Ironwood and AbbVie Secure FDA Expansion for LINZESS in Young Children for ... Read Post »
New Drug ApprovalFDA Clears AbbVie’s DECNUPAZ as First CD123 ADC for BPDCN FDA Clears AbbVie’s DECNUPAZ as First CD123 ADC for BPDCN Read Post »
Clinical TrialsAligos Shows Long-Term Pevifoscorvir Activity in Chronic HBV Aligos Shows Long-Term Pevifoscorvir Activity in Chronic HBV Read Post »
Clinical TrialsArrowhead Reports Liver Fat Reduction With ARO-INHBE in Obesity and MASH Arrowhead Reports Liver Fat Reduction With ARO-INHBE in Obesity and MASH Read Post »
Clinical TrialsBiohaven Shows Early Clinical Gains in Graves’ Disease and IgAN Biohaven Shows Early Clinical Gains in Graves’ Disease and IgAN Read Post »
Clinical TrialsAltimmune Reports Strong Fibrosis Improvements With Pemvidutide in MASH Altimmune Reports Strong Fibrosis Improvements With Pemvidutide in MASH Read Post »
Clinical TrialsGilead Presents Long-Term Livdelzi Phase 3 Results at EASL 2026 Gilead Presents Long-Term Livdelzi Phase 3 Results at EASL 2026 Read Post »
Clinical TrialsIdefirix Advances Toward Full EU Approval After Positive PAES Results Idefirix Advances Toward Full EU Approval After Positive PAES Results Read Post »
Clinical TrialsLIB Showcases Long-Term LEROCHOL® Data at EAS 2026 LIB Showcases Long-Term LEROCHOL® Data at EAS 2026 Read Post »
Clinical TrialsSobi Reports 85% Lower Pancreatitis Risk with Olezarsen in sHTG Sobi Reports 85% Lower Pancreatitis Risk with Olezarsen in sHTG Read Post »
New Drug ApprovalApotex Wins Health Canada Approval for IHEEZO Eye Anesthetic Gel Apotex Wins Health Canada Approval for IHEEZO Eye Anesthetic Gel Read Post »
Clinical TrialsKura Reports Encouraging Responses in KRAS G12C Cancers at ASCO 2026 Kura Reports Encouraging Responses in KRAS G12C Cancers at ASCO 2026 Read Post »
Clinical TrialsBiohaven’s Opakalim Nears Regulatory Filing as Biohaven Reports New Epile... Biohaven’s Opakalim Nears Regulatory Filing as Biohaven Reports New Epile... Read Post »
Clinical TrialsDyne Therapeutics Files BLA for DYNE‑251 in DMD Dyne Therapeutics Files BLA for DYNE‑251 in DMD Read Post »
ResearchNovo Nordisk Presents New Data on Residual Cardiovascular Inflammation Novo Nordisk Presents New Data on Residual Cardiovascular Inflammation Read Post »
New Drug ApprovalVyepti Wins South Korea Approval for Adult Migraine Vyepti Wins South Korea Approval for Adult Migraine Read Post »
Clinical TrialsLilly’s VERVE-102 Cuts LDL-C by Up to 62% in Phase 1b Heart-2 Study Lilly’s VERVE-102 Cuts LDL-C by Up to 62% in Phase 1b Heart-2 Study Read Post »
New Drug ApprovalEC Approves Pharming’s Joenja for Activated PI3K Delta Syndrome EC Approves Pharming’s Joenja for Activated PI3K Delta Syndrome Read Post »
Drugs Safety AlertTakeda’s ADZYNMA Gets FDA Boxed Warning After Fatal Antibody Case Takeda’s ADZYNMA Gets FDA Boxed Warning After Fatal Antibody Case Read Post »
New Drug ApprovalGalderma Wins FDA Approval for OTC Differin Epiduo Acne Gel Galderma Wins FDA Approval for OTC Differin Epiduo Acne Gel Read Post »
New Drug ApprovalEC Grants EU‑Wide Approval for PYRUKYND in Thalassemia EC Grants EU‑Wide Approval for PYRUKYND in Thalassemia Read Post »
Clinical TrialsCHMP Backs AbbVie’s MAVIRET for Acute Hepatitis C in Adults and Children CHMP Backs AbbVie’s MAVIRET for Acute Hepatitis C in Adults and Children Read Post »
Clinical TrialsEli Lilly’s Foundayo Shows Up to 13% Weight Loss in Older Adults in ATTAI... Eli Lilly’s Foundayo Shows Up to 13% Weight Loss in Older Adults in ATTAI... Read Post »
New Drug ApprovalAstraZeneca and Daiichi Sankyo Secure FDA Approval for Datroway in Frontlin... AstraZeneca and Daiichi Sankyo Secure FDA Approval for Datroway in Frontlin... Read Post »
New Drug ApprovalGilead’s Hepcludex Becomes First FDA-Approved HDV Therapy Gilead’s Hepcludex Becomes First FDA-Approved HDV Therapy Read Post »
Clinical TrialsInnovent’s IBI363 Demonstrates Durable Efficacy in NSCLC Innovent’s IBI363 Demonstrates Durable Efficacy in NSCLC Read Post »
Clinical TrialsBoehringer Ingelheim Unveils New Zongertinib and Obrixtamig Results Across ... Boehringer Ingelheim Unveils New Zongertinib and Obrixtamig Results Across ... Read Post »
New Drug ApprovalBayer Wins NMPA Approval for Kerendia in HFmrEF/HFpEF Bayer Wins NMPA Approval for Kerendia in HFmrEF/HFpEF Read Post »
New Drug ApprovalHERNEXEOS Secures China Approval for Untreated HER2-Mutant NSCLC HERNEXEOS Secures China Approval for Untreated HER2-Mutant NSCLC Read Post »
Clinical TrialsBiogen Ends BIIB122 Program, Denali Continues Trial in LRRK2 Carriers Biogen Ends BIIB122 Program, Denali Continues Trial in LRRK2 Carriers Read Post »
Clinical TrialsSobi’s Pozdeutinurad Delivers Positive Phase 3 Results in Gout Sobi’s Pozdeutinurad Delivers Positive Phase 3 Results in Gout Read Post »
Clinical TrialsBicycle Reports Positive Duravelo 2 Results for Zelenectide in mUC Bicycle Reports Positive Duravelo 2 Results for Zelenectide in mUC Read Post »
Clinical TrialsReCode’s Inhaled mRNA Therapy Shows First Clinical Activity in PCD ReCode’s Inhaled mRNA Therapy Shows First Clinical Activity in PCD Read Post »
Clinical TrialsLilly’s Retatrutide Achieves 30.3% Weight Loss in Phase 3 TRIUMPH-1 Trial Lilly’s Retatrutide Achieves 30.3% Weight Loss in Phase 3 TRIUMPH-1 Trial Read Post »
Clinical TrialsInfex Advances RESP-X After Positive Bronchiectasis Phase IIa Results Infex Advances RESP-X After Positive Bronchiectasis Phase IIa Results Read Post »
Clinical TrialsBioMarin VOXZOGO Improves Growth and Reach in Children BioMarin VOXZOGO Improves Growth and Reach in Children Read Post »
Clinical TrialsPalvella Strengthens QTORIN’s FDA Path With New SELVA and TOIVA Data Palvella Strengthens QTORIN’s FDA Path With New SELVA and TOIVA Data Read Post »
Clinical TrialsSavara Reports New Phase 3 Biomarker Data Supporting Molgramostim in aPAP Savara Reports New Phase 3 Biomarker Data Supporting Molgramostim in aPAP Read Post »
Clinical TrialsRelay’s Zovegalisib Shows Rapid Lesion Reduction in Rare Vascular Disorde... Relay’s Zovegalisib Shows Rapid Lesion Reduction in Rare Vascular Disorde... Read Post »
Clinical TrialsRemepy Advanced Hybridopa After Positive Parkinson’s Trial Results Remepy Advanced Hybridopa After Positive Parkinson’s Trial Results Read Post »
Clinical TrialsShionogi Advances Tapinarof With Positive Infant Atopic Dermatitis Data Shionogi Advances Tapinarof With Positive Infant Atopic Dermatitis Data Read Post »
Clinical TrialsIpsen’s Dysport Holds Its Ground Against Botox in Head-to-Head Study Ipsen’s Dysport Holds Its Ground Against Botox in Head-to-Head Study Read Post »
Clinical TrialsANKTIVA Plus BCG Outperforms Approved NMIBC Therapies in AUA 2026 Analyses ANKTIVA Plus BCG Outperforms Approved NMIBC Therapies in AUA 2026 Analyses Read Post »
Clinical TrialsInnovent’s Dual-Target Antibody IBI3002 Shows Promise in Asthma Innovent’s Dual-Target Antibody IBI3002 Shows Promise in Asthma Read Post »
Clinical TrialsUCB Pushes BIMZELX Ahead of SKYRIZI in Psoriatic Arthritis Showdown UCB Pushes BIMZELX Ahead of SKYRIZI in Psoriatic Arthritis Showdown Read Post »
Clinical TrialsWave Expands Evidence for WVE-006 in Lung and Liver Manifestations of AATD Wave Expands Evidence for WVE-006 in Lung and Liver Manifestations of AATD Read Post »
